Universal-Beteiligungs- und Servicegesellschaft
OCUL icon

Universal-Beteiligungs- und Servicegesellschaft’s Ocular Therapeutix OCUL Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
169,064
+3,080
+2% +$27.9K ﹤0.01% 1373
2026
Q1 		$1.41M Buy
165,984
+147,845
+815% +$1.41M ﹤0.01% 1385
2025
Q4 		$220K Buy
+18,139
New +$220K ﹤0.01% 1957

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's OCUL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Ocular Therapeutix (OCUL) stake by 1.9% in Q2 2026, buying an estimated $27.9K and bringing the position to 169,064 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 169,064 shares of Ocular Therapeutix worth $1.66M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 3,080 Ocular Therapeutix shares in Q2 2026, an estimated $27.9K.
  • Ocular Therapeutix made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1373 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.